• Info
  • Insider Trading

Insider Transactions Reported by 14 Insiders of Trillium Therapeutics Inc.

Location
Mississauga, Ontario, Canada

There are no Buy or Sell transactions made by insiders since 12 Mar 2025

Trillium Therapeutics Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Paolo Pucci Director 17 Nov 2021
Scott Dunseth Myers Director 17 Nov 2021
Paul Edward Walker Director 17 Nov 2021
LUKE M. BESHAR Director 17 Nov 2021
Parsons James T. Chief Financial Officer 17 Nov 2021
Michael E. Kamarck Director 17 Nov 2021
Robert Uger Chief Scientific Officer 17 Nov 2021
Rosemary Harrison Title: Senior Vice President, Corporate Development and Strategy 17 Nov 2021
Jan Skvarka President and CEO, Director 17 Nov 2021
Helen Tayton-Martin Director 17 Nov 2021
Penka Petrova Chief Development Officer 17 Nov 2021
Ingmar Bruns Chief Medical Officer 17 Nov 2021
CATHERINE J. MACKEY Director 17 Nov 2021
Benjamin Looker General Counsel 17 Nov 2021

Recent Insider Transactions by Companies or Individuals for Trillium Therapeutics Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.